Study of Patients Being Treated With Anti-obesity Medication

Part of paid clinical trials in Lubbock, Texas.

Sponsor
Texas Tech University
Study ID
NCT06790160
Status
Recruiting
Apply to this trial

Conditions

  • Obesity and Overweight

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The goal of this observational study is to learn about the real-world effects of selected obesity medications in adults undergoing medical weight management. The main outcomes of interest are changes in body composition, routine clinical markers, muscular performance, and nutritional intake over the course of treatment. Additionally, the influence of lifestyle factors on changes in these outcome variables will be examined. Participants beginning treatment with selected obesity medications will undergo periodic body composition and muscular performance testing, as well as complete online surveys about their nutritional intake and physical activity and exercise participation. Additionally, routinely collected clinical information will be evaluated.

Key Dates

Start date
Jan 31, 2025
Status verified
May 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Patients undergoing obesity treatment
    This cohort will be comprised of individuals who are beginning obesity medication treatment at a specified virtual obesity medicine practice. Patients taking semaglutide or tirzepatide may be eligible for inclusion in this cohort.

Primary Outcome Measure

Change in Total Lean Soft Tissue [ Time Frame: From baseline assessment to last available time point (follow-up assessments conducted ~6 months and ~17 months after baseline). ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Texas Tech UniversityLubbockTexas79409
Grant Tinsley
[email protected]
806-834-5895

Find similar trials in Lubbock, TX

By research site
Texas Tech University· Lubbock, TX

Related Studies